Combination of CCR5 and CXCR4 Inhibitors in Therapy of Human Immunodeficiency Virus Type 1 Infection: In Vitro Studies of Mixed Virus Infections

Схожие документы

• Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors
  по: Rusconi, Stefano, et al.
  Опубликовано: (2000)
• In Vitro Evolution of the Human Immunodeficiency Virus Type 1 Gag-Protease Region and Maintenance of Reverse Transcriptase Resistance following Prolonged Drug Exposure
  по: La Seta Catamancio, Simona, et al.
  Опубликовано: (2001)
• Inhibition of Human Immunodeficiency Virus Replication by a Dual CCR5/CXCR4 Antagonist
  по: Princen, Katrien, et al.
  Опубликовано: (2004)
• Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants
  по: Mosier, Donald E., et al.
  Опубликовано: (1999)
• Induction of CD8(+) Cells Able To Suppress CCR5-Tropic Simian Immunodeficiency Virus SIVmac239 Replication by Controlled Infection of CXCR4-Tropic Simian-Human Immunodeficiency Virus in Vaccinated Rhesus Macaques
  по: Tsukamoto, Tetsuo, et al.
  Опубликовано: (2007)